Mustang Bio Inc. (MBIO)
NASDAQ: MBIO
· Real-Time Price · USD
1.60
-0.02 (-1.23%)
At close: Sep 25, 2025, 3:59 PM
1.58
-1.25%
After-hours: Sep 25, 2025, 04:46 PM EDT
-1.23% (1D)
Bid | 1.59 |
Market Cap | 11.59M |
Revenue (ttm) | 1.99M |
Net Income (ttm) | -3.28M |
EPS (ttm) | 1.99 |
PE Ratio (ttm) | 0.8 |
Forward PE | -0.02 |
Analyst | n/a |
Dividends | n/a |
Ask | 1.65 |
Volume | 53,708 |
Avg. Volume (20D) | 5,760,950 |
Open | 1.62 |
Previous Close | 1.62 |
Day's Range | 1.59 - 1.64 |
52-Week Range | 0.89 - 21.95 |
Beta | 2.23 |
Ex-Dividend Date | n/a |
About MBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MBIO
Website n/a
2 months ago
+180.67%
Mustang Bio shares are trading higher after the co...
Unlock content with
Pro Subscription
2 months ago
+114.64%
Mustang Bio shares are trading higher after the company announced it received FDA Orphan Drug designation status for MB-101.